Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Catto

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
BJU International|September 24, 2013
Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA)Christine Gan, Amit Patel, Sarah Fowler, et al.
BJU International|May 14, 2016
Consensus guidelines for reporting prostate cancer Gleason GradeAnthony Zietman, Joseph Smith, Eric Klein, et al.
European Urology|March 26, 2016
Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now RequiredAnthony Zietman, Joseph Smith, Eric Klein, et al.
Urology|March 27, 2016
Consensus Guidelines for Reporting Prostate Cancer Gleason GradeAnthony Zietman, Joseph Smith, Eric Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2016
Editorial Statement on Gleason Scoring for Prostate CancerAnthony L Zietman, Joseph Smith, Eric Klein, et al.
European Urology Focus|July 30, 2017
Islam and the Urinary Stoma: A Contemporary Theological and Urological DilemmaSaiful Miah, Altaf Mangera, Nadir I Osman, et al.
Urologic Oncology|May 9, 2016
New Gleason grading system: Statement from the Editors of six journalsAnthony Zietman, Joseph Smith, Eric Klein, et al.
European Urology|February 27, 2016
The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These CancersGiorgio Gandaglia, Alberto Briganti, Nicola Fossati, et al.
European Urology Oncology|October 9, 2025
Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder CancerJavier Molina-Cerrillo, James Catto, Ashish M Kamat, et al.
Oncotarget|October 21, 2016
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapyKarl Patterson, Lovleen Arya, Sarah Bottomley, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
BJU International|September 24, 2013
Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA)Christine Gan, Amit Patel, Sarah Fowler, et al.
BJU International|May 14, 2016
Consensus guidelines for reporting prostate cancer Gleason GradeAnthony Zietman, Joseph Smith, Eric Klein, et al.
European Urology|March 26, 2016
Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now RequiredAnthony Zietman, Joseph Smith, Eric Klein, et al.
Urology|March 27, 2016
Consensus Guidelines for Reporting Prostate Cancer Gleason GradeAnthony Zietman, Joseph Smith, Eric Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2016
Editorial Statement on Gleason Scoring for Prostate CancerAnthony L Zietman, Joseph Smith, Eric Klein, et al.
European Urology Focus|July 30, 2017
Islam and the Urinary Stoma: A Contemporary Theological and Urological DilemmaSaiful Miah, Altaf Mangera, Nadir I Osman, et al.
Urologic Oncology|May 9, 2016
New Gleason grading system: Statement from the Editors of six journalsAnthony Zietman, Joseph Smith, Eric Klein, et al.
European Urology|February 27, 2016
The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These CancersGiorgio Gandaglia, Alberto Briganti, Nicola Fossati, et al.
European Urology Oncology|October 9, 2025
Revisiting Neoadjuvant Chemotherapy in Cisplatin-eligible Muscle-invasive Bladder CancerJavier Molina-Cerrillo, James Catto, Ashish M Kamat, et al.
Oncotarget|October 21, 2016
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapyKarl Patterson, Lovleen Arya, Sarah Bottomley, et al.
Pageof 6